- 
Chinese (Simplified)
 - 
zh-CN
English
 - 
en
French
 - 
fr
German
 - 
de
Hindi
 - 
hi
Russian
 - 
ru
Spanish
 - 
es
Vietnamese
 - 
vi

Key Advisors

J. Dianne Keen-Kim, PhD, FACMG,
HCLD(ABB) CLIA Lab Director

black fab icon
Dr. J. Dianne Keen-Kim joined Artemis DNA to direct the CLIA Laboratory in January 2021. After earning her B.S. from Carnegie Mellon and Ph.D. from MIT in Clinical Molecular Genetics and Clinical Cytogenetics. Dr. Keen-Kim completed fellowships at UCLA and is certified by the American Board of Medical Genetics and Genomics (ABMGG) in both molecular genetics and cytogenetics, as well as the American Board or Bioanalysis (HCLD).
Dr. Keen-Kim maintains clinical director licenses in CA and NY, and has expertise in building, validating, and process-improving clinical laboratory tests, including automating manual assays. She serves as Laboratory Director for Artemis DNA CA.

Cynthe Sims, PhD, HCLD (ABB)
Lab Director

black fab icon
Dr. Cynthe Sims has a deep understanding and expertise in clinical laboratory solutions, clinical genomics, precision medicine, molecular diagnostics and next generation sequencing. Dr. Sims has assisted small laboratories, Fortune 500 companies, international government agencies and large healthcare systems plan and launch their precision medicine initiatives.
Dr. Sims is licensed in the State of Florida (Director License in Molecular Pathology), New York state (COQ) and in California State (CGMBS) and holds HCLD board certification (ABB) in molecular diagnostics.

Owatha Loye “Tootie” Tatum, PhD,
HCLD/CC(ABB), MBA CEO, Blackhawk Genomics

black fab icon
Dr. Owatha “Tootie” Tatum has been a key advisor since 2021. Dr. Tatum is an experienced executive with a demonstrated history of excellence in the biotechnology and diagnostics industry. Skilled in healthcare strategy, business development, DNA sequencing, quality management, Next Generation Sequencing (NGS), molecular biology, and biotechnology, Dr. Tatum earned her Ph.D in Biomedical Sciences and MBA from the University of California, Berkeley, Haas School of Business.

Shaohan Zhao, PhD, MBA
CEO, Zhao Laboratory Consulting

black fab icon
Dr. Shaohan Zhao has been a key advisor since 2019. Dr. Zhao received his Ph.D. in 2001 in Toxicology and his MBA in 2002 from Iowa State University. Dr. Zhao is a board-certified toxicologist as a fellow by the American Board of Forensic Toxicology and has been serving as lab director for multiple clinical labs since 2011, specializing in lab management, technical guidance and compliance with CLIA, COLA and CAP regulations.
Dr. Zhao is also a certified lab director for the state of New York (category of Toxicology, Genetic Testing and Virology), New Jersey, Florida, Nevada and Louisiana and is a member of the Society of Forensic Toxicology and the Southwestern Association of Toxicologists.

Giang Nguyen, MD
CEO, AVA Plastic, Reconstructive and Cosmetic Surgery Hospital

black fab icon
Dr. Giang Nguyen was originally born and raised in Vietnam. She immigrated to the United States in 2002 to study as an international student and graduated magna cum laude from the University of California, Irvine in 2008 with a degree in Biological Science. She subsequently obtained her medical degree at Medical College of Wisconsin and completed her General Surgery Residency training at LAC-USC Hospital, University of Southern California.
Dr. Nguyen is currently the CEO of AVA Plastic, Reconstructive and Cosmetic Surgery Hospital in Ho Chi Minh City, Vietnam. She is an active member of American College of Surgeons. She is specialized in minimal invasive plastic reconstructive surgery and is a founding member of Inmode Pioneers Club of which primary mission is to develop and expand the field of minimal invasive plastic reconstructive surgery in Vietnam.

Khoi Thai
Consultant

black fab icon
Mr. Khoi Thai has been a key advisor since 2021. Mr. Thai received his Bachelors of Science in Chemical Engineering, Biotechnology Focus, in 2004 from University of California, Berkeley. Mr. Thai is a chemical engineer with over 15 years of experience in biotechnology, spanning process development and cGMP manufacturing as part of the industry and on the vendor side.
Mr. Thai have worked on and led teams working on large, complex projects across functional areas. He spent the last 8 years working with single use technology, and has leveraged single use technology to enable rapid start up of a single use facility for clinical production as well as rapid transfer to a CMO for commercialization.
Top